An Assessment of the Screening Method to Evaluate Vaccine Effectiveness: The Case of 7-Valent Pneumococcal Conjugate Vaccine in the United States | PLOS ONE
An Assessment of the Screening Method to Evaluate Vaccine Effectiveness: The Case of 7-Valent Pneumococcal Conjugate Vaccine in the United States | PLOS ONE
![Modelling infectious diseases with herd immunity in a randomly mixed population | Scientific Reports Modelling infectious diseases with herd immunity in a randomly mixed population | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-00013-2/MediaObjects/41598_2021_13_Fig3_HTML.png)
Modelling infectious diseases with herd immunity in a randomly mixed population | Scientific Reports
![Updating Herd Immunity Models for the U.S. in 2020: Implications for the COVID-19 Response | medRxiv Updating Herd Immunity Models for the U.S. in 2020: Implications for the COVID-19 Response | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/10/06/2020.10.05.20207100/F3.large.jpg)
Updating Herd Immunity Models for the U.S. in 2020: Implications for the COVID-19 Response | medRxiv
![A Data Science View of Herd Immunity, What do We Have to Pay to Stop The Virus? | by Catherine Wang | Towards Data Science A Data Science View of Herd Immunity, What do We Have to Pay to Stop The Virus? | by Catherine Wang | Towards Data Science](https://miro.medium.com/v2/resize:fit:1400/1*CVCV_kVczMD8f_bxDbKwTA.png)
A Data Science View of Herd Immunity, What do We Have to Pay to Stop The Virus? | by Catherine Wang | Towards Data Science
![Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia | medRxiv Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia | medRxiv](https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2020/12/19/2020.12.15.20248278/embed/graphic-12.gif)